Part 3/9:
The Secretary highlighted the prevalent issue of unfair trade practices that have led to a significant trade deficit. He pointed out that many American industries, particularly pharmaceuticals, have suffered due to policies that enable other countries to capitalize on cheaper production costs. “Why are all of our pharmaceutical products… made in Asia?” he questioned, labeling the trend as a consequence of misguided trade policies that benefit foreign markets at the expense of American manufacturing.